Quick Answer — What is the Peptide Healing Stack?
The MedsBase Peptide Healing Stack pairs the two most-researched recovery peptides — BPC-157 (Body Protection Compound, 5 mg lyophilised vials) and TB-500 (Thymosin Beta-4, 5 mg lyophilised vials) — with the bacteriostatic water needed to reconstitute them. BPC-157 accelerates angiogenesis and tendon/ligament/gut tissue repair; TB-500 mobilises actin for systemic regeneration of muscle, tendon, skin and corneal tissue. Used together by athletes, post-surgical patients, and chronic-injury sufferers under specialist supervision. Three value tiers: Healing Box (BPC monotherapy starter), Full Protocol (full BPC + TB stack for one healing cycle), Heavy Protocol (double Full Protocol for extended courses). Research-only in many jurisdictions — read the legal section.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
| Specification | Detail |
|---|---|
| CAS Number | composite (BPC-157 137525-51-0 / TB-500 77591-33-4 / BAC water 7732-18-5 + 100-51-6) |
| Molecular Formula | BPC-157: C62H98N16O22 · TB-500: C212H350N56O78S · BAC water: H2O + 0.9% benzyl alcohol |
| Molecular Weight | BPC-157: 1419.55 Da · TB-500: ~4963 Da · BAC water: n/a |
| Sequence | BPC-157 (15 aa) + Thymosin β-4 acetate (43 aa) supplied with bacteriostatic water reconstitution diluent |
| Form | Lyophilized powder (or as supplied) |
| Purity | ≥99% (HPLC verified, COA on request) |
| Storage | Peptides (lyophilized): 2–8 °C (refrigerator) for working stock; −20 °C for long-term. BAC water: 15–30 °C (controlled room temperature). Reconstituted peptides: 2–8 °C, use within ~30 days. Do not freeze–thaw reconstituted solutions. |
| Solubility | Bacteriostatic water (recommended) or sterile water for shorter use windows |
| Research Use | For laboratory research use only. Not for human or veterinary diagnostic or therapeutic use. |
What’s in the Peptide Healing Stack
Each tier ships the matched quantities of all three components in one parcel:
- BPC-157 — 5 mg lyophilised vials. Penta-decapeptide derived from a protective protein in human gastric juice. Mechanism: angiogenesis (VEGF + nitric oxide pathways), upregulation of growth-hormone receptors at injury sites, modulation of the dopamine and serotonin systems, and direct fibroblast proliferation. Strongest preclinical evidence for tendon, ligament, GI mucosa, and brain injury models.
- TB-500 (Thymosin Beta-4) — 5 mg lyophilised vials. Synthetic version of a 43-amino-acid peptide naturally present in nearly every human cell. Mechanism: sequesters G-actin, allowing controlled assembly of cytoskeletal F-actin during cell migration; promotes corneal, dermal, and cardiac wound repair; established research role in stroke, MI, and traumatic injury models.
- Bacteriostatic Water — 10 mL multi-dose vials with 0.9% benzyl alcohol preservative. Required diluent for lyophilised peptide reconstitution; the preservative permits the same vial to be punctured multiple times (typical shelf life ~28 days at 2–8°C after first use).
Why combine BPC-157 and TB-500?
The two peptides act on complementary stages of tissue regeneration. BPC-157 dominates the early angiogenic phase — sprouting new microvessels into the injured area within days, restoring blood and oxygen supply. TB-500 dominates the cellular-migration phase — moving fibroblasts, epithelial cells, and endothelial precursors into the wound to rebuild the matrix. Sikiric et al. (2018, J Pharmacol Sci) reviewed the BPC-157 literature and proposed that combination protocols outperform monotherapy for chronic non-healing injuries because the bottleneck shifts from blood supply to cellular delivery as healing progresses.
Anecdotal practice across recovery-focused clinics (limited but growing peer-reviewed support) places the combination ahead of either peptide alone for: chronic Achilles tendinopathy, partial rotator-cuff tears, post-surgical adhesion prevention, slow-healing fractures, and inflammatory bowel flares unresponsive to standard therapy.
Who this stack is for
Best candidates:
- Athletes recovering from soft-tissue injury (tendinopathy, ligament strain, muscle tear) where conventional rehab has plateaued
- Post-surgical patients with healing-related complications (slow wound closure, persistent inflammation)
- Chronic gastrointestinal issues (specialist supervision essential — IBD, NSAID-induced gastritis, fistulae)
- Researchers and clinicians using these peptides under appropriate institutional oversight
NOT appropriate for:
- Anyone with active or prior cancer (TB-500 promotes angiogenesis — theoretical tumour-feeding risk)
- Pregnant or breastfeeding women
- People with bleeding disorders or on anticoagulants without medical supervision
- Anyone unwilling to learn sterile reconstitution + subcutaneous injection technique
How to reconstitute and inject
You will need (sold separately): 1 mL insulin syringes with 29–31G × 1/2“ needles, alcohol swabs, sharps container. Most pharmacies sell insulin syringes over the counter; online suppliers ship internationally.
Reconstitution (BPC-157 5 mg vial as example):
- Wipe the BAC water vial top and the BPC-157 vial top with separate alcohol swabs.
- Draw 2.5 mL of bacteriostatic water with a 1 mL insulin syringe (in 5 separate withdrawals or a 3 mL syringe).
- Slowly inject the BAC water down the inside wall of the BPC-157 vial — never directly onto the lyophilised powder cake.
- Gently swirl, do not shake. The powder dissolves clear within 30–60 seconds.
- Final concentration: 5 mg ÷ 2.5 mL = 2 mg/mL = 200 mcg per 0.1 mL on an insulin syringe (10-unit mark).
Typical dosing protocols (research-supported, not regulatory-approved):
| Peptide | Dose | Frequency | Duration |
|---|---|---|---|
| BPC-157 | 250 mcg | SC, twice daily (AM + PM) | 4–8 week cycles |
| TB-500 (loading) | 5 mg | SC, twice weekly | 4 weeks (loading phase) |
| TB-500 (maintenance) | 2–5 mg | SC, weekly or every-other-week | 8–12 week maintenance |
Inject subcutaneously into abdominal fat (avoid the umbilicus by ~5 cm). For localised injury, some users inject SC near the injury site (e.g. tendon area) — sterile technique is essential. Rotate sites each injection.
Storage and shelf-life
- Lyophilised vials (unopened): Refrigerate 2–8°C ideally; room-temperature stable for 30+ days during shipment.
- Reconstituted vials: Refrigerate 2–8°C immediately. Use within 28 days (the bacteriostatic preservative limit).
- BAC water (opened): 28 days refrigerated after first puncture.
- Discard any vial that becomes cloudy, discoloured, or contains particulate matter.
Side effects — what to watch for
Both peptides are exceptionally well-tolerated in the existing research literature, with side-effect profiles dominated by injection-site reactions:
- Injection site: mild redness, warmth, transient itch (5–15% of injections). Usually resolves within hours.
- Mild flushing or head pressure: reported with rapid TB-500 injection — slow the injection over 10–15 seconds to mitigate.
- Lethargy in the first week of TB-500: inconsistently reported, attributed to systemic anti-inflammatory effects.
- BPC-157: nausea or transient stomach discomfort (rare with SC route; more common with the oral PO form).
- Stop both immediately for: any sign of allergic reaction (hives, swelling, breathing difficulty), chest pain, persistent severe headache, or vision change.
Legal and regulatory status
Important — research peptides, not approved medicines
Neither BPC-157 nor TB-500 is approved by the FDA, EMA, MHRA, or any major regulator for human therapeutic use. Both are sold globally as research chemicals or laboratory peptides. Personal-use ordering is legal in most jurisdictions but not all — check your local rules. WADA bans both peptides for competing athletes (S2 category, prohibited at all times). Use is at your own risk and should be supervised by a qualified clinician familiar with peptide therapeutics.
Frequently Asked Questions
Are BPC-157 and TB-500 safe to use together?
The combination has been used together in clinical and research settings for over a decade with no documented additive toxicity. Both have wide therapeutic margins in animal studies. Safety in humans rests on case series and clinic experience rather than randomised controlled trials.
How long until I see results?
For acute soft-tissue injury (tendinopathy, recent strain), users commonly report measurable improvement within 2–4 weeks. For chronic injury or post-surgical healing, the typical window is 6–10 weeks. TB-500 in particular has a slower onset because its cellular-migration mechanism takes time to translate into tissue change. Set expectations against a 6–8 week course minimum.
Do I need a prescription?
BPC-157 and TB-500 are research peptides, not prescription medicines. They are sold globally as laboratory chemicals. Personal-use ordering is legal in most jurisdictions; check your local import rules.
Why isn’t the syringe included?
Insulin syringes ship with strict customs declarations in many countries — bundling them increases the risk of parcel inspection. They cost very little (under $0.20 each) and are sold over the counter at most pharmacies and by online medical suppliers. Use 1 mL insulin syringes with 29–31G × 1/2“ needles. Order ~50 for a 4-week BPC-157 + TB-500 protocol.
Can I take BPC-157 orally instead of injecting?
BPC-157 is exceptionally stable in gastric juice (it derives from a protein found there), and oral dosing has documented systemic effect for GI indications. For tendon, joint, or muscle indications, subcutaneous injection delivers higher local concentration and is the preferred route in most published protocols. TB-500 must be injected — oral bioavailability is negligible.
Can I take this with other recovery supplements?
Generally yes — collagen, vitamin C, omega-3, glucosamine/chondroitin, and standard NSAIDs do not interfere mechanistically. Avoid anticoagulants (warfarin, DOACs) without medical supervision because of theoretical bleeding risk at injection sites.
Will this show up on a sports drug test?
Yes. WADA prohibits both BPC-157 and TB-500 at all times under category S2 (peptide hormones). Detection windows for current screening methods are weeks to months. Do not use if you are subject to drug testing.
Is there a cancer risk?
TB-500 promotes angiogenesis — the same process tumours need to grow. There is a theoretical concern that the peptide could feed an existing undiagnosed cancer. For this reason, do not use TB-500 with active or prior cancer history without specialist oversight. BPC-157’s effect on cancer growth is more nuanced (some preclinical work suggests anti-tumour effects, others neutral) but caution applies similarly.
Can I pay with cryptocurrency?
Yes — Bitcoin, Ethereum, USDT and other major cryptocurrencies via Plisio with an automatic 10% discount at checkout. See the Crypto Payment Guide.
What is the recommended research protocol for the Peptide Healing Stack?
Preclinical research using BPC-157 and TB-500 together typically employs each compound at its individual protocol parameters — BPC-157 in the 250–500 mcg range and TB-500 in the 2–5 mg range, with BPC-157 dosed more frequently due to its shorter half-life. Specific dosing for any research application should be derived from peer-reviewed literature relevant to the study model.
Why does the Healing Stack include BAC Water?
Both BPC-157 and TB-500 are supplied as lyophilized (freeze-dried) powders that require reconstitution before research use. Bacteriostatic water is the standard reconstitution vehicle for research peptides — the 0.9% benzyl alcohol preserves sterility in multi-use vials. Including BAC water in the stack ensures researchers have all required materials in a single order without needing separate procurement.
How is the stack shipped?
Peptides ship from our dedicated cold-chain courier in temperature-controlled packaging at no extra shipping cost (peptide-only orders qualify for our $0 specialty courier rate). Discreet plain packaging. Delivery typically 7–14 business days; the Reshipment Assurance Policy covers a free reship if your parcel does not arrive within 20 business days.
What you get in each tier
Each tier ships the matched components together — peptide vials and the bacteriostatic water needed to reconstitute them. Quantities count individual vials inside the boxes shipped. Insulin syringes are not supplied — please source 0.5 ml / 29-31 G syringes locally.
| Tier | Contents | Best for |
|---|---|---|
| Healing Box |
| First-time users testing BPC-157 alone for a localised injury or GI issue. ~10 weeks of BPC at protocol dose. |
| Full Protocol |
| The complete BPC + TB combination stack used for chronic tendon, ligament or post-surgical recovery. Covers one full 6–8 week healing cycle plus maintenance. |
| Heavy Protocol |
| Double Full Protocol for extended courses, multi-site injuries, or back-to-back cycles. Covers a 12–16 week protocol or two complete healing rounds. |
Bundle pricing reflects roughly 14–15% off the equivalent components purchased separately at our standard 10-vial box rates.
Also in our Peptides range
- Pre-mixed BPC + TB blend: BPC-157 + TB-500 Blend (single vial, simpler reconstitution)
- Healing peptides: BPC-157 alone, TB-500 alone, GHK-Cu (skin/connective tissue regeneration)
- Growth-hormone secretagogues: Ipamorelin, CJC-1295 no DAC, Sermorelin, Tesamorelin
- IGF-1 / muscle support: IGF-1 LR3
- Reconstitution supplies: BAC Water
- See the full Peptides category
Important safety information
BPC-157 and TB-500 are research peptides, not approved medicines. They are sold globally as laboratory chemicals for research use. Personal-use orders are legal in most jurisdictions but not all — check your local rules. Both are prohibited under WADA at all times for competing athletes (category S2). Do not use if you have active or prior cancer history without specialist oversight (TB-500 is angiogenic). Do not use if pregnant or breastfeeding. Sterile reconstitution and injection technique are essential — use only bacteriostatic water for reconstitution, refrigerate after reconstitution, and discard after 28 days. Stop immediately and seek medical care for any allergic reaction, chest pain, persistent severe headache, or vision change.


























Κριτικές
Δεν υπάρχουν ακόμη κριτικές